| Department of Medicine

DOM In the News

Read about how the Department of Medicine is responding to the outbreak of the coronavirus respiratory illness COVID-19. See related COVID-19 publications.

A Design of Experiment (DoE) approach to optimise spray drying process conditions for the production of trehalose/leucine formulations with application in pulmonary delivery.

Lung epithelial cells induce endodermal differentiation in mouse mesenchymal bone marrow stem cells by paracrine mechanism.

COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.

Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report.

A Year of Deaths Due to or With COVID-19 Under Universal Postmortem Testing in San Francisco.

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trial.

FY 2023-2024 Fellows

Welcome UCSF Geriatrics FY2023-2024 Fellows!

Please join us in welcoming our current year's cohort of Geriatrics Fellows!

Fellows

Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor.

Tuberculosis outbreak investigation using phylodynamic analysis.

Levels of HIV testing and low validity of self-reported test results among alcoholics and drug users.

Ligand-receptor interactions required for commitment to the activation of the interleukin 2 gene.

Obesity and Fat Metabolism in HIV-infected Individuals: Immunopathogenic Mechanisms and Clinical Implications.

Endogenous Testosterone Levels and the Risk of Incident Cardiovascular Events in Elderly Men: The MrOS Prospective Study.

Abstract A37: Efficient identification of low-income women at high risk for hereditary breast cancer and referral to genetic counseling.

Development of an asthma health-care burden score as a measure of severity and predictor of remission in SARP III and U-BIOPRED: results from two major longitudinal asthma cohorts.